Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Volixibat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mirum Pharma Reveals Q1 2026 Financials And Business Update
    Mirum Pharma Reveals Q1 2026 Financials And Business Update

    06 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7275076

    FIRSTWORD PHARMA
    06 May 2026
    Share Share
    Mirum's rare liver Disease Drug Meets Main Goal in Mid-Stage
    Mirum's rare liver Disease Drug Meets Main Goal in Mid-Stage

    04 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/mirums-rare-liver-disease-drug-meets-main-goal-mid-stage-study-2026-05-04/

    REUTERS
    04 May 2026
    Share Share
    Mirum Highlights LIVMARLI And Volixibat Data At Liver Meeting
    Mirum Highlights LIVMARLI And Volixibat Data At Liver Meeting

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107860621/en/Mirum-Pharmaceuticals-Showcases-Leadership-in-Liver-Disease-Innovation-With-Data-From-LIVMARLI-and-Volixibat-Clinical-Programs-at-AASLDs-The-Liver-Meeting

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL

    09 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250509189818/en/Volixibat-Data-from-Mirums-VANTAGE-PBC-Study-Showcased-at-EASL

    BUSINESSWIRE
    09 May 2025
    Share Share
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114053418/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617178174/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.